Resumen
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
Título traducido de la contribución | Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 518-519 |
Número de páginas | 2 |
Publicación | Revista Chilena de Infectologia |
Volumen | 34 |
N.º | 5 |
DOI | |
Estado | Publicada - oct. 2017 |
Publicado de forma externa | Sí |
Nota bibliográfica
Publisher Copyright:© 2018, Sociedad Chilena de Infectologia. All rights reserved.
Palabras clave
- Crohn´s colitis
- Inflammatory bowel disease
- Pneumocystis carinii
- Pneumocystis jiroveci
- Ulcerative colitis